EGFR and lung adenocarcinoma: On the other hand, genetic studies involving multi-region sequencing of tumors have clearly shown that genetic heterogeneity exists in lung adenocarcinoma and EGFR mutations generally occur in the genetic trunk of the tumor and are hence clonal, whereas KRAS mutations are often sub-clonal (2).